C-reactive protein upregulates complement-inhibitory factors in endothelial cells

被引:76
作者
Li, SH [1 ]
Szmitko, PE [1 ]
Weisel, RD [1 ]
Wang, CH [1 ]
Fedak, PWM [1 ]
Li, RK [1 ]
Mickle, DAG [1 ]
Verma, S [1 ]
机构
[1] Univ Toronto, Div Cardiac Surg, Toronto, ON, Canada
关键词
endothelium; atherosclerosis; proteins;
D O I
10.1161/01.CIR.0000117087.27524.0E
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background - Because complement-mediated vascular injury participates in atherosclerosis and C-reactive protein (CRP) can activate the complement cascade, we sought to determine whether CRP affects the expression of the protective complement-inhibitory factors on the cell surface of endothelial cells (ECs). Methods and Results - Human coronary artery or human saphenous vein ECs were incubated with CRP ( 0 to 100 mug/mL, 0 to 72 hours), and the expression of the complement-inhibitory proteins decay-accelerating factor (DAF), membrane cofactor protein (CD46), and CD59 were measured by flow cytometry. Incubation with CRP resulted in a significant increase in the expression of all 3 proteins. CRP-induced upregulation of DAF required increased steady-state mRNA and de novo protein synthesis. The increased expression of complement-inhibitory proteins was functionally effective, resulting in significant reduction of complement-mediated lysis of antibody-coated human saphenous vein ECs. Conclusions - These observations provide evidence for a possible protective role for CRP in atherogenesis.
引用
收藏
页码:833 / 836
页数:4
相关论文
共 22 条
  • [1] BERMAN S, 1986, J IMMUNOL, V136, P1354
  • [2] Complement and atherogenesis - Binding of CRP to degraded, nonoxidized LDL enhances complement activation
    Bhakdi, S
    Torzewski, M
    Klouche, M
    Hemmes, M
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (10) : 2348 - 2354
  • [3] C-reactive protein: a surrogate risk marker or mediator of atherothrombosis?
    Blake, GJ
    Ridker, PM
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2003, 285 (05) : R1250 - R1252
  • [4] Vascular smooth muscle cell activation by C-reactive protein
    Hattori, Y
    Matsumura, M
    Kasai, K
    [J]. CARDIOVASCULAR RESEARCH, 2003, 58 (01) : 186 - 195
  • [5] Liszewski MK, 1996, ADV IMMUNOL, V61, P201
  • [6] Induction of decay-accelerating factor by cytokines or the membrane-attack complex protects vascular endothelial cells against complement deposition
    Mason, JC
    Yarwood, H
    Sugars, K
    Morgan, BP
    Davies, KA
    Haskard, DO
    [J]. BLOOD, 1999, 94 (05) : 1673 - 1682
  • [7] Statin-induced expression of decay-accelerating factor protects vascular endothelium against complement-mediated injury
    Mason, JC
    Ahmed, Z
    Mankoff, R
    Lidington, EA
    Ahmad, S
    Bhatia, V
    Kinderlerer, A
    Randi, AM
    Haskard, DO
    [J]. CIRCULATION RESEARCH, 2002, 91 (08) : 696 - 703
  • [8] Mason JC, 2001, ARTHRITIS RHEUM, V44, P138, DOI 10.1002/1529-0131(200101)44:1<138::AID-ANR18>3.0.CO
  • [9] 2-G
  • [10] EFFECTS OF TRANSFECTED COMPLEMENT REGULATORY PROTEINS, MCP, DAF, AND MCP/DAF HYBRID, ON COMPLEMENT-MEDIATED SWINE ENDOTHELIAL-CELL LYSIS
    MIYAGAWA, S
    SHIRAKURA, R
    IWATA, K
    NAKATA, S
    MATSUMIYA, G
    IZUTANI, H
    MATSUDA, H
    TERADO, A
    MATSUMOTO, M
    NAGASAWA, S
    SEYA, T
    [J]. TRANSPLANTATION, 1994, 58 (07) : 834 - 840